Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:238-244
Published online before print January 3, 2006, doi: 10.1161/01.HYP.0000200023.02195.73
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
47/2/238    most recent
01.HYP.0000200023.02195.73v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modlinger, P.
Right arrow Articles by Wilcox, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modlinger, P.
Right arrow Articles by Wilcox, C. S.
Related Collections
Right arrow Other hypertension

(Hypertension. 2006;47:238.)
© 2006 American Heart Association, Inc.


Original Articles

RNA Silencing In Vivo Reveals Role of p22phox in Rat Angiotensin Slow Pressor Response

Paul Modlinger; Tinatin Chabrashvili; Pritomhinder S. Gill; Margarida Mendonca; David G. Harrison; Kathy K. Griendling; Min Li; Julie Raggio; Anton Wellstein; Yifan Chen; William J. Welch; Christopher S. Wilcox

From the Division of Cardiology (D.G.H., K.K.G.), Emory University, Atlanta, Ga; Angiogenesis Section (P.S.G., A.W., Y.C., W.J.W., C.W.), Lombardi Cancer Center, and Cardiovascular-Kidney Institute and Division of Nephrology and Hypertension (P.M., T.C., P.S.G., M.M., M.L., J.R., Y.C., W.J.W., C.S.W.) Georgetown University, Washington, DC.

Correspondence to Christopher S. Wilcox, Georgetown University Medical Center–PHC F6003, 3800 Reservoir Rd, NW, Washington, DC 20007. E-mail wilcoxch{at}georgetown.edu

The angiotensin II (Ang II) slow-pressor response entails an increase in mean arterial pressure and reactive oxygen species. We used double-stranded interfering RNAs (siRNAs) in Sprague Dawley rats in vivo to test the hypothesis that an increase in the p22phox component of NADPH oxidase is required for this response. Reactive oxygen species were assessed from excretion of 8-isoprostane prostaglandin F2{alpha} and blood pressure by telemetry. Two siRNA sequences to p22phox (sip22phox) reduced mRNA >85% in cultured vascular smooth muscle cells. Rats received rapid (10 second) IV injections (50 to 100 µg) of 1 of 2 different sip22phox, control siRNA, or vehicle (TransIt in saline) during 14 day SC infusions of Ang II (200 ng · kg–1 · min–1) or sham infusions. In both groups, sip22phox, relative to control siRNA, led to significant (P<0.001; {approx}50%) reductions in expression of p22phox mRNA and protein and of NADPH oxidase activity in the kidney cortex. In Ang II–infused rats, sip22phox decreased protein expression for Nox-1, -2, and -4 but increased p47phox. Three days after sip22phox, conscious rats infused with Ang II had a reduced excretion of 8-isoprostane (10±1 versus 19±2 pg · 24 h–1; P<0.01) and a reduced mean arterial pressure (142±5 versus 168±4 mm Hg; P<0.005). An increase in p22phox is required for increased renal NADPH oxidase activity, expression of Nox proteins and oxidative stress, and contributes ≤50% to hypertension during an Ang II slow-pressor response.


Key Words: hypertension, arterial • arterioles • oxidative stress • kidney




This article has been cited by other articles:


Home page
HypertensionHome page
W. J. Welch
Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction
Hypertension, July 1, 2008; 52(1): 51 - 56.
[Full Text] [PDF]


Home page
Diabetes CareHome page
T. M. Paravicini and R. M. Touyz
NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. F.M.Z. Clemente, T. F. Tornatore, T. H. Theizen, A. C. Deckmann, T. C. Pereira, I. Lopes-Cendes, J. R. M. Souza, and K. G. Franchini
Targeting Focal Adhesion Kinase With Small Interfering RNA Prevents and Reverses Load-Induced Cardiac Hypertrophy in Mice
Circ. Res., December 7, 2007; 101(12): 1339 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Wang, P. S. Gill, T. Chabrashvili, M. L. Onozato, J. Raggio, M. Mendonca, K. Dennehy, M. Li, P. Modlinger, J. Leiper, et al.
Isoform-Specific Regulation by NG,NG-Dimethylarginine Dimethylaminohydrolase of Rat Serum Asymmetric Dimethylarginine and Vascular Endothelium-Derived Relaxing Factor/NO
Circ. Res., September 14, 2007; 101(6): 627 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Sachse and G. Wolf
Angiotensin II Induced Reactive Oxygen Species and the Kidney
J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2439 - 2446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Nouri, P. Gill, M. Li, C. S. Wilcox, and W. J. Welch
p22phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1685 - H1689.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. J. Welch, T. Chabrashvili, G. Solis, Y. Chen, P. S. Gill, S. Aslam, X. Wang, H. Ji, K. Sandberg, P. Jose, et al.
Role of Extracellular Superoxide Dismutase in the Mouse Angiotensin Slow Pressor Response
Hypertension, November 1, 2006; 48(5): 934 - 941.
[Abstract] [Full Text] [PDF]